INBRAIN Neuroelectronics announces FDA Breakthrough Device Designation for Its Graphene-Based Intelligent Network Modulation Platform
| Date | 20th, Sep 2023 |
|---|---|
| Source | Graphene Info - Scientific and Educational Websites |
DESCRIPTION
INBRAIN Neuroelectronics, a health-tech company dedicated to developing intelligent graphene-neural platform, has announced that its Intelligent Network Modulation System has been granted Breakthrough Device Designation (BDD) from the U.S. Food & Drug Administration (FDA) as an adjunctive therapy for treating Parkinson’s disease.